| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lars Holtug is Director at ASND. Lars Holtug's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
The ASND filings lean toward selling, a net 236 shares.
Lars Holtug has 1 Form 4 filing on record in September 2026, as Director at Ascendis Pharma A/S (ASND), 2026.
The 1 reported transaction was 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $62K.
The only open-market sale was 236 shares of ASND at an average $264.13 on September 2, 2026, about $62K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ASND Ascendis Pharma A/s | Director | Sell | 236 | $264.13 | $62,334.59 | -5.6% | - | - |